EVH
Evolent Health Inc - Ordinary Shares - Class A

1,618
Mkt Cap
$438.98M
Volume
1.98M
52W High
$12.98
52W Low
$3.50
PE Ratio
-2.47
EVH Fundamentals
Price
$3.92
Prev Close
$3.88
Open
$3.89
50D MA
$5.98
Beta
0.86
Avg. Volume
5.63M
EPS (Annual)
-$0.8149
P/B
0.51
Rev/Employee
$567,720.22
Loading...
Loading...
News
all
press releases
Evolent Health, Inc (NYSE:EVH) Receives Average Recommendation of "Moderate Buy" from Analysts
Evolent Health, Inc (NYSE:EVH - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the sixteen brokerages that are currently covering the company, MarketBeat.com reports...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
Walleye Capital LLC Boosts Stock Position in Evolent Health, Inc $EVH
Walleye Capital LLC increased its stake in Evolent Health, Inc (NYSE:EVH - Free Report) by 1,198.0% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The...
MarketBeat·5d ago
News Placeholder
Citigroup Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price
Citigroup decreased their price target on shares of Evolent Health from $11.50 to $9.50 and set a "buy" rating on the stock in a research note on Friday...
MarketBeat·19d ago
News Placeholder
Evolent Health (NYSE:EVH) Director Acquires $38,200.00 in Stock
Evolent Health, Inc (NYSE:EVH - Get Free Report) Director Brendan Springstubb bought 10,000 shares of the company's stock in a transaction dated Tuesday, November 18th. The stock was bought at an...
MarketBeat·21d ago
News Placeholder
Evolent Health, Inc $EVH Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp cut its position in shares of Evolent Health, Inc (NYSE:EVH - Free Report) by 14.9% during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·23d ago
News Placeholder
Evolent Health (NYSE:EVH) Price Target Cut to $9.00 by Analysts at Canaccord Genuity Group
Canaccord Genuity Group decreased their target price on shares of Evolent Health from $16.00 to $9.00 and set a "buy" rating for the company in a research note on Friday...
MarketBeat·25d ago
News Placeholder
Stephens Upgrades Evolent Health (NYSE:EVH) to Overweight
Stephens raised shares of Evolent Health from an "equal weight" rating to an "overweight" rating and set a $7.00 price target for the company in a research report on Thursday...
MarketBeat·27d ago
News Placeholder
BMO Capital Markets Initiates Coverage on Evolent Health (NYSE:EVH)
BMO Capital Markets assumed coverage on Evolent Health in a report on Thursday. They set an "outperform" rating and a $7.00 target price on the stock...
MarketBeat·27d ago
News Placeholder
Oppenheimer Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price
Oppenheimer decreased their price objective on shares of Evolent Health from $18.00 to $12.00 and set an "outperform" rating for the company in a research report on Wednesday...
MarketBeat·28d ago
News Placeholder
Truist Financial Lowers Evolent Health (NYSE:EVH) Price Target to $10.00
Truist Financial cut their target price on shares of Evolent Health from $16.00 to $10.00 and set a "buy" rating on the stock in a research note on Monday...
MarketBeat·1mo ago

Latest EVH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.